Joe M Viljoen Selected Research

Cutaneous Tuberculosis (Scrofuloderma)

6/2022	Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems.
1/2019	Topical Delivery of Artemisone, Clofazimine and Decoquinate Encapsulated in Vesicles and Their In vitro Efficacy Against Mycobacterium tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joe M Viljoen Research Topics

Disease

2	Cutaneous Tuberculosis (Scrofuloderma) 06/2022 - 01/2019
1	Malaria 01/2022
1	Neoplasms (Cancer) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020

Drug/Important Bio-Agent (IBA)

2	Clofazimine (Lamprene)FDA Link 06/2022 - 01/2019
2	artemisoneIBA 01/2020 - 01/2019
1	EmulsionsIBA 01/2022
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	ArtemisininsIBA 01/2020
1	artenimol (dihydroartemisinin)IBA 01/2020
1	elesclomolIBA 01/2020
1	PiperazineIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	artemisinin (artemisinine)IBA 01/2020
1	Oxidants (Oxidizing Agents)IBA 01/2020
1	DecoquinateIBA 01/2019

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 01/2019